Selective and iron-independent ferroptosis in cancer cells induced by manipulation of mitochondrial fatty acid oxidation

Despite the promise of Ferroptosis in Cancer therapy, selectively inducing robust Ferroptosis in Cancer cells remains a significant challenge. In this study, manipulation of fatty acids β-oxidation (FAO) by combination of mild photodynamic therapy (PDT) and inhibition of triglycerides (TGs) synthesis was found to induce robust and iron-independent Ferroptosis in Cancer cells with dysregulated lipid metabolism for the first time. To achieve that, TGs synthesis inhibitor of xanthohumol (Xan) and FAO initiator of tetrakis (4-carboxyphenyl) porphyrin (TCPP) were co-delivered by a nanoplexes composed of pH-responsive amphiphilic Lipopeptide C₁₈-pHis₁₀ and DSPE-PEG₂₀₀₀. TCPP was found to rapidly increase the intracellular ROS under laser irradiation without inducing antioxidant response and Apoptosis, activating the AMPK in Cancer cells and accelerating mitochondrial FAO. Xan fueled the mitochondrial FAO with substrates by suppressing the conversion of fatty acids (FAs) to TGs. This also led to augmented intracellular polyunsaturated fatty acids (PUFAs) and PUFAs-phospholipids levels, increasing the intrinsic susceptibility of Cancer cells to lipid peroxidization. As a result, the excessive ROS generated from the sustained mitochondrial FAO caused remarkably lipid peroxidation and ultimately Ferroptosis. Collectively, our study provides a new approach to selectively induce iron-independent Ferroptosis in Cancer cells by taking advantage of dysregulated lipid metabolism.

Cancer cell selective; Dysregulated lipid metabolism; Fatty acids β-oxidation; Iron-independent ferroptosis; Positive-feedback.